# Study of Olutasidenib and Temozolomide in HGG

> clinical trial · VERIFIED · 2026-06-12

Status: RECRUITING · Sponsor: Rigel Pharmaceuticals · Condition: High Grade Glioma

- Company: Rigel Pharmaceuticals
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06161974

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.